Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease M Marchese, D Cowan, E Head, D Ma, K Karimi, V Ashthorpe, M Kapadia, ... Journal of Alzheimer's Disease 39 (1), 191-210, 2014 | 93 | 2014 |
Autoimmune and inflammatory mechanisms of CNS damage M Kapadia, B Sakic Progress in neurobiology 95 (3), 301-333, 2011 | 93 | 2011 |
The water maze paradigm in experimental studies of chronic cognitive disorders: Theory, protocols, analysis, and inference M Kapadia, J Xu, B Sakic Neuroscience & Biobehavioral Reviews 68, 195-217, 2016 | 40 | 2016 |
Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death ML De Snoo, EL Friesen, YT Zhang, R Earnshaw, G Dorval, M Kapadia, ... Cell Death & Disease 10 (12), 907, 2019 | 33 | 2019 |
Altered olfactory function in the MRL model of CNS lupus M Kapadia, M Stanojcic, AM Earls, S Pulapaka, J Lee, B Sakic Behavioural Brain Research 234 (2), 303-311, 2012 | 21 | 2012 |
Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans KS Chen, K Menezes, JB Rodgers, DM O’Hara, N Tran, K Fujisawa, ... Molecular Neurodegeneration 16, 1-25, 2021 | 17 | 2021 |
Sex-dependent differences in spontaneous autoimmunity in adult 3xTg-AD mice M Kapadia, MF Mian, B Michalski, AB Azam, D Ma, P Salwierz, ... Journal of Alzheimer's Disease 63 (3), 1191-1205, 2018 | 17 | 2018 |
Altered neuroendocrine status at the onset of CNS lupus-like disease G Loheswaran, M Kapadia, M Gladman, S Pulapaka, L Xu, M Stanojcic, ... Brain, Behavior, and Immunity 32, 86-93, 2013 | 14 | 2013 |
Effects of sustained icv infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling M Kapadia, D Bijelić, H Zhao, D Ma, L Stojanovich, M Milošević, P Andjus, ... Acta Neuropathologica Communications 5 (1), 70, 2017 | 12 | 2017 |
Sustained immunosuppression alters olfactory function in the MRL model of CNS lupus M Kapadia, H Zhao, D Ma, B Sakic Journal of Neuroimmune Pharmacology 12, 555-564, 2017 | 12 | 2017 |
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease S Nim, DM O’Hara, C Corbi-Verge, A Perez-Riba, K Fujisawa, M Kapadia, ... Nature Communications 14 (1), 2150, 2023 | 11 | 2023 |
Zoopharmacognosy in diseased laboratory mice: conflicting evidence M Kapadia, H Zhao, D Ma, R Hatkar, M Marchese, B Sakic PLoS One 9 (6), e100684, 2014 | 10 | 2014 |
Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members M Kapadia, ML De Snoo, LV Kalia, SK Kalia Neural Regeneration Research 16 (4), 684-685, 2021 | 7 | 2021 |
Semi-quantitative determination of dopaminergic neuron density in the substantia Nigra of rodent models using automated image analysis DM O'Hara, M Kapadia, S Ping, SK Kalia, LV Kalia JoVE (Journal of Visualized Experiments), e62062, 2021 | 7 | 2021 |
Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice M Kapadia, MF Mian, D Ma, CP Hutton, A Azam, K Narkaj, C Cao, ... Alzheimer's Research & Therapy 13, 1-22, 2021 | 6 | 2021 |
Behavioral phenotyping of murine disease models with the Integrated Behavioral Station (INBEST) B Sakic, MPA Cooper, SE Taylor, M Stojanovic, B Zagorac, M Kapadia JoVE (Journal of Visualized Experiments), e51524, 2015 | 6 | 2015 |
P1–024: Immunological dysfunction and MCI‐like behavior in the 3xTgAD mice M Marchese, D Cowan, K Karimi, V Ashthorpe, E Head, D Ma, H Zhao, ... Alzheimer's & Dementia 9, P161-P161, 2013 | 1 | 2013 |
Mitophagy Upregulation Occurs Early in the Neurodegenerative Process Mediated by α-Synuclein S Hui, J George, M Kapadia, H Chau, Z Bariring, R Earnshaw, K Shafiq, ... Molecular Neurobiology, 1-11, 2024 | | 2024 |
Reduction of alpha synuclein oligomers in preclinical models of Parkinson’s disease by electrical stimulation in vitro and deep brain stimulation in vivo EJ Lee, DH Aguirre-Padilla, A Fomenko, G Pawar, M Kapadia, J George, ... Brain Stimulation, 2024 | | 2024 |
A novel peptide reduces a-synuclein levels and neurodegeneration in cell, invertebrate, and mammalian models of Parkinson's disease D O'Hara, S Nim, K Hall, M Kapadia, M De Snoo, H Chau, S Ngana, ... MOVEMENT DISORDERS 35, S228-S228, 2020 | | 2020 |